| Literature DB >> 25494969 |
Dianbo Yao, Shuodong Wu1, Yongnan Li, Yongsheng Chen, Xiaopeng Yu, Jinyan Han.
Abstract
BACKGROUND: Single-incision laparoscopic surgery (SILS), which has been demonstrated to be safely applied on kinds of surgeries, may represent an improvement over conventional multi-port laparoscopic surgery. However, there are still few clinical experiences of SILS in pancreatic surgery until now. In this study, we will summarize our experience of transumbilical single-incision laparoscopic distal pancreatectomy (TUSI-LDP), and compare its related parameters with conventional multi-port laparoscopic distal pancreatectomy (C-LDP).Entities:
Mesh:
Year: 2014 PMID: 25494969 PMCID: PMC4277826 DOI: 10.1186/1471-2482-14-105
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Figure 1Operating room setting and access site in the umbilicus. (A) Operating room setting: the operator, assistants and monitor. (B) Access site in the umbilicus: the two trocars for the lens, grasper, and the plastic disposable trocar, for the ultrasonic scalpel.
Figure 2Operative procedure of laparoscopic distal pancreatectomy. (A) Exposure of pancreas. The lesion is seen at the right side of the picture. (B) The body to tail of the pancreas is mobilized and lifted from the retroperitoneum by a cloth tape, and pancreatic body is transected with an endoscopic linear stapler device. (C) The lesion was put into a retrieval bag. (D) The cyst contents were aspirated within the retrieval bag. (E) The closed drains brought out through the transumbilical incision. (F) The lesion, the serous cystadenoma in pathologic diagnosis.
General information of 14 cases
| Patient number | Diagnosis | Tumor location | Age | Sex | BMI | Maximum diameter of lesion |
|---|---|---|---|---|---|---|
| 1 | Mucinous cystadenoma | body of pancreas | 46 | F | 24.6 | 5 |
| 2 | Fibromatosis | abdominal cavity | 20 | F | 18.6 | 3.5 |
| 3 | Serositic cyst | tail of pancreas | 36 | F | 23.4 | 4.5 |
| 4 | Pancreatic cyst | body of pancreas | 42 | F | 22.2 | 4.5 |
| 5 | Artery aneurysm | spleen | 22 | F | 21.6 | 3.5 |
| 6 | Mucinous cystadenoma and SPT | body and tail of pancreas | 34 | F | 22.8 | 3.5 |
| 7 | Pancreatic cyst | tail of pancreas | 34 | F | 23.4 | 3.5 |
| 8 | Mucinous cystadenoma | body and tail of pancreas | 39 | F | 22.6 | 3 |
| 9 | Islet cell tumor | tail of pancreas | 73 | F | 26.2 | 1.2 |
| 10 | Mucinous cystadenoma | body and tail of pancreas | 27 | F | 22.2 | 4 |
| 11 | Mucinous cystadenoma | tail of pancreas | 45 | F | 21.8 | 6.2 |
| 12 | Serous cystadenoma | tail of pancreas | 50 | F | 21.5 | 3.2 |
| 13 | Mucinous cystadenoma | tail of pancreas | 37 | F | 18.4 | 11 |
| 14 | Artery aneurysm | spleen | 58 | M | 27.0 | 3.8 |
BMI body mass index; SPT solid-pseudopapillary tumor.
Operative parameters and postoperative recovery of patients
| Cases | Operation time (min) | Intraoperative blood loss (ml) | Conversion to multi-incision surgery | Postoperative evacuating time (day) | Food intake time (day) | Drainage time (day) | Hospital stay (day) | Postoperative hemorrhage | Pancreatic leakage |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 300 | 500 | yes | 3 | 3 | 4 | 8 | no | no |
| 2* | 240 | 500 | no | 4 | 4 | 7 | 9 | no | no |
| 3 | 150 | 10 | no | 3 | 3 | >7 | 7 | no | yes |
| 4 | 125 | 100 | no | 4 | 5 | 7 | 8 | no | no |
| 5 | 170 | 10 | no | 3 | 3 | 4 | 6 | no | no |
| 6* | 110 | 30 | no | 3 | 3 | 4 | 6 | no | no |
| 7* | 115 | 50 | no | 2 | 3 | 7 | 8 | no | no |
| 8* | 165 | 100 | no | 5 | 5 | 10 | 10 | no | no |
| 9# | 170 | 50 | no | 3 | 4 | 7 | 8 | no | no |
| 10 | 155 | 200 | no | 4 | 5 | 7 | 7 | no | no |
| 11 | 95 | 200 | no | 3 | 4 | 5 | 5 | no | no |
| 12# | 120 | 50 | no | 3 | 4 | 6 | 7 | no | no |
| 13* | 185 | 200 | no | 3 | 4 | 7 | 9 | no | no |
| 14 | 230 | 200 | no | 5 | 5 | 8 | 9 | no | no |
*Splenic preservation; #Splenic and its vessels preservation.
Demographical characteristics of the patients
| SILS (n =14) | Conventional (n = 7) | P | |
|---|---|---|---|
| Age, mean ± SD [range] | 40.2 ± 14.1 [20–73] | 50.4 ± 11.3 [35–65] | 0.66 |
| Sex (% men) | 7.1 | 14.3 | 0.61 |
| Weight, mean ± SD [range] | 59.6 ± 8.9 [45–80] | 60.4 ± 5.1 [54–67] | 0.21 |
| BMI, mean ± SD [range], kg/m2 | 22.6 ± 2.4 [18.4–27.0] | 23.3 ± 1.3 [21.3–25.2] | 0.29 |
| Size of lesion,, mean ± SD [range], cm | 4.3 ± 2.2 [1.2–11] | 3.7 ± 2.2 [0.7–6.0] | 0.47 |
| Lesion type (benign/malignant) | 0/14 | 1/6 | 0.16 |
Operative and postoperative results
| SILS (n =14) | Conventional (n = 7) | P | |
|---|---|---|---|
| Operating time, mean ± SD, min | 166.4 ± 57.4 | 202.1 ± 122.5 | 0.15 |
| Estimated blood loss,mean ± SD, ml | 157.1 ± 162.4 | 168.6 ± 157.4 | 0.66 |
| Scale of pain, mean ± SD | 0.7 ± 0.6 | 1.1 ± 0.7 | 0.90 |
| Conversion to open surgery, % | 1/14 | 1/7 | 0.61 |
| Complications, % | 1/14 | 0/7 | 0.48 |
| Length of hospital stay, mean ± SD, d | 7.6 ± 1.4 | 9.0 ± 3.0 | 0.17 |